MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Depreciation & Amortization 2011-2026 | NVTA
Annual Depreciation & Amortization Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 M | 80.5 M | 39 M | 16.2 M | 13.5 M | 9.18 M | 6.55 M | 5.32 M | 2.32 M | 928 K | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 142 M | 928 K | 31.6 M |
Quarterly Depreciation & Amortization Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.2 M | 5 M | 35 M | - | 9.7 M | 5.8 M | 27.1 M | - | 56.8 M | 35.3 M | 16.6 M | - | 23 M | 14.5 M | 6.06 M | - | 11.1 M | 6.72 M | 3.29 M | - | 10.3 M | 6.93 M | 3.43 M | - | 5.88 M | 3.49 M | 1.73 M | - | 4.93 M | 3.25 M | 1.56 M | - | 3.72 M | 2.3 M | 1.02 M | - | 1.57 M | 967 K | 471 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 56.8 M | 471 K | 10.4 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 27.63 | -4.06 % | $ 297 M |  China |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
130 K | $ 105.79 | 0.61 % | $ 4.17 B | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 209.19 | -0.82 % | $ 149 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 11.26 | - | $ 319 M |  Israel |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | Israel |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 23.09 | 0.35 % | $ 698 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 209.54 | 1.02 % | $ 23.3 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 29.94 | 3.46 % | $ 832 M | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 19.25 | 2.45 % | $ 1.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 287.13 | 0.64 % | $ 23.9 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
252 M | $ 73.09 | -0.23 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
300 K | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.43 | 1.14 % | $ 410 M | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | $ 103.45 | 0.06 % | $ 19.5 B | USA |
 |
Natera
NTRA
|
16.7 M | $ 209.53 | 0.09 % | $ 20.6 B | USA |
 |
Pacific Biosciences of California
PACB
|
11.5 M | $ 1.66 | 5.06 % | $ 421 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 95.4 | 1.04 % | $ 12 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
403 M | $ 166.06 | 1.55 % | $ 8.23 B | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 104.09 | -0.54 % | $ 8.59 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
46.5 K | $ 3.86 | 2.93 % | $ 2.07 M | USA |
 |
IDEXX Laboratories
IDXX
|
145 M | $ 649.23 | 4.19 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
354 M | $ 122.9 | 1.96 % | $ 19.5 B | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 164.88 | 1.58 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 379.66 | -0.97 % | $ 28.4 B |  Schweiz |
|
Biodesix
BDSX
|
5.77 M | $ 13.02 | 1.96 % | $ 1.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 48.54 | 0.94 % | $ 2.9 B | USA |